These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1381313)

  • 1. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
    Wyss-Coray T; Brander C; Frutig K; Pichler WJ
    Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-induced T cell clones: specificity, MHC restriction, proliferation and cytokine pattern as a function of different stimulations.
    Pichler WJ; Brander C; Mauri D; Frutig K; Wyss-Coray T
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):141-53; discussion 153-4. PubMed ID: 7873053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
    Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
    Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
    Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
    Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.
    Van Der Pouw Kraan TT; Stiekema FE; Teunissen MB; Bos JD; Kapsenberg L
    Immunology; 1989 Oct; 68(2):147-53. PubMed ID: 2572541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified HLA class II peptide complexes can induce adherence and activation of peptide-specific human T cell clones.
    van Schooten WC; Maiore T; Jones KR; Paborsky L
    J Immunol; 1992 Feb; 148(4):1043-8. PubMed ID: 1531349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
    Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
    Walker PR; Fellowes R; Hecht EM; Lehner T
    J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranes of activated CD4+ T cells expressing T cell receptor (TcR) alpha beta or TcR gamma delta induce IgE synthesis by human B cells in the presence of interleukin-4.
    Gascan H; Aversa GG; Gauchat JF; Van Vlasselaer P; Roncarolo MG; Yssel H; Kehry M; Spits H; De Vries JE
    Eur J Immunol; 1992 May; 22(5):1133-41. PubMed ID: 1349531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
    Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
    Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.
    Hecht TT; Longo DL; Matis LA
    J Immunol; 1983 Sep; 131(3):1049-55. PubMed ID: 6193170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.
    Spits H; Paliard X; Vandekerckhove Y; van Vlasselaer P; de Vries JE
    J Immunol; 1991 Aug; 147(4):1180-8. PubMed ID: 1831219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.